13F-HR filed by JACOBS LEVY EQUITY MANAGEMENT, INC
JACOBS LEVY EQUITY MANAGEMENT, INC filed this 13F-HR for the quarter ended 2018-06-30, filed 2018-08-14, with 1,013 holding rows worth $6,361,898,000.
- Accession
- 0001085146-18-002127
- Filer
- CIK 884414
- Filed
- 2018-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2018
A combination report, 1,013 entries on the cover page, a total value of $6,361,898,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $6,361,898,000 with VALUE read as thousands by filing date, 13F file number 028-03059. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerAMERIPRISE FINANCIAL INC028-00139
- reports for this filerRussell Investments Group, Ltd.028-17598
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| NAVIDEA BIOPHARMACEUTICALS I | 63937X103 | COM | 353,202 | $81,000 | thousands by filing date | |
| EP ENERGY CORP | 268785102 | CL A | 26,100 | $78,000 | thousands by filing date | |
| HC2 HLDGS INC | 404139107 | COM | 12,800 | $75,000 | thousands by filing date | |
| SAFE BULKERS INC | Y7388L103 | COMMON STOCK | 21,212 | $72,000 | thousands by filing date | |
| BSQUARE CORP | 11776U300 | COM | 25,299 | $68,000 | thousands by filing date | |
| Arsanis Inc | 042873109 | COM | 11,492 | $42,000 | thousands by filing date | |
| SCYNEXIS INC COM NEW | 811292101 | Common Stock | 21,100 | $35,000 | thousands by filing date | |
| OBALON THERAPEUTICS INC | 67424L100 | COM | 11,100 | $24,000 | thousands by filing date | |
| PLURISTEM THERAPEUTICS INC | 72940R102 | COM | 17,800 | $22,000 | thousands by filing date | |
| ACTINIUM PHARMACEUTICALS INC | 00507W107 | COM | 28,594 | $18,000 | thousands by filing date | |
| CELLDEX THERAPEUTICS INC NEW | 15117B103 | COM | 29,000 | $15,000 | thousands by filing date | |
| AGILE THERAPEUTICS INC | 00847L100 | COM | 31,272 | $15,000 | thousands by filing date | |
| RADISYS CORP | 750459109 | COM | 19,681 | $14,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-18-002127 | this filing | 2018-08-14 | acceptance time not in the bulk data set |